International Assets Investment Management LLC Increases Stake in Option Care Health, Inc. (NASDAQ:OPCH)

International Assets Investment Management LLC increased its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 3,029.7% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,848 shares of the company’s stock after purchasing an additional 2,757 shares during the quarter. International Assets Investment Management LLC’s holdings in Option Care Health were worth $91,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in the business. Thrivent Financial for Lutherans increased its holdings in shares of Option Care Health by 9.1% in the second quarter. Thrivent Financial for Lutherans now owns 5,459,119 shares of the company’s stock worth $151,218,000 after buying an additional 455,310 shares during the period. Westfield Capital Management Co. LP grew its position in Option Care Health by 15.4% during the 1st quarter. Westfield Capital Management Co. LP now owns 5,171,385 shares of the company’s stock worth $173,448,000 after acquiring an additional 688,653 shares during the last quarter. Dimensional Fund Advisors LP grew its position in Option Care Health by 6.5% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,605,271 shares of the company’s stock worth $99,870,000 after acquiring an additional 218,844 shares during the last quarter. Magnetar Financial LLC increased its stake in Option Care Health by 124.8% in the 2nd quarter. Magnetar Financial LLC now owns 2,481,935 shares of the company’s stock worth $68,750,000 after purchasing an additional 1,377,929 shares during the period. Finally, Massachusetts Financial Services Co. MA bought a new stake in Option Care Health in the second quarter valued at approximately $68,003,000. 98.05% of the stock is owned by institutional investors.

Insider Buying and Selling

In other news, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the completion of the sale, the director now directly owns 21,339 shares in the company, valued at approximately $663,429.51. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, Director Elizabeth Quadros Betten sold 47,531 shares of the firm’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the transaction, the director now directly owns 21,339 shares of the company’s stock, valued at approximately $663,429.51. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Michael H. Shapiro sold 23,217 shares of Option Care Health stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total transaction of $718,566.15. Following the sale, the chief financial officer now directly owns 247,317 shares of the company’s stock, valued at $7,654,461.15. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.64% of the stock is currently owned by corporate insiders.

Option Care Health Stock Down 2.4 %

OPCH opened at $22.93 on Friday. The firm’s fifty day moving average is $29.98 and its 200 day moving average is $29.74. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The stock has a market cap of $3.90 billion, a price-to-earnings ratio of 19.23, a price-to-earnings-growth ratio of 2.33 and a beta of 1.32. Option Care Health, Inc. has a fifty-two week low of $22.25 and a fifty-two week high of $34.63.

Analyst Ratings Changes

Several research analysts have recently issued reports on OPCH shares. Barrington Research cut their target price on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a report on Thursday, October 31st. The Goldman Sachs Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and cut their price target for the stock from $38.00 to $27.00 in a report on Monday. JMP Securities upped their price objective on shares of Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research note on Monday, September 30th. Bank of America lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $43.00 to $29.00 in a report on Wednesday, October 30th. Finally, Jefferies Financial Group downgraded Option Care Health from a “buy” rating to a “hold” rating and reduced their price target for the company from $38.00 to $26.00 in a report on Thursday, October 31st. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, Option Care Health currently has a consensus rating of “Moderate Buy” and an average target price of $30.83.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.